macular damage
Showing 1 - 25 of 8,551
Macular Damage in Early Glaucoma and Progression
Recruiting
- Glaucoma
-
New York, New YorkCUIMC Harkness Eye Institute
Nov 4, 2022
Comparison of 3D Visualization and Microscope for VR Surgery Trial in Rovigo (Macular surgery with NGENUITY surgical display
Completed
- Comparison of 3D Visualization and Microscope for VR Surgery
- Macular surgery with NGENUITY surgical display system
- Macular surgery with standard operating microscope
-
Rovigo, ItalySanta Maria della Misericordia Hospital
Dec 21, 2022
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Age Related Macular Degeneration Trial in Bern (NUTROF TOTAL)
Completed
- Age Related Macular Degeneration
- NUTROF TOTAL
-
Bern, SwitzerlandDepartment of Ophthalmology, Inselspital, Bern University Hostpi
Jan 24, 2023
Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)
Not yet recruiting
- Macular Edema
- +2 more
- subthreshold treatment with micropulsed laser
-
Rome, RM, ItalyIRCSS Fondazione G:B:Bietti
Jul 27, 2023
Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)
Recruiting
- Retinal Disease
- +17 more
- Arm 1
-
Westport, Connecticut
- +2 more
Nov 25, 2022
Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food Trial (luteine and zeaxanthine, luteine, zeaxanthine)
Not yet recruiting
- Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food
- luteine and zeaxanthine
- +3 more
- (no location specified)
Mar 20, 2023
Age-Related Macular Degeneration Trial in United States (Iptacopan (LNP023), Placebo)
Recruiting
- Age-Related Macular Degeneration
- Iptacopan (LNP023)
- Placebo
-
Sacramento, California
- +9 more
Sep 20, 2022
Macular Pigmentation, Skin Pigment Trial in Salt Lake City (Carotenoid measurements)
Recruiting
- Macular Pigmentation
- Skin Pigment
- Carotenoid measurements
-
Salt Lake City, UtahUniversity of Utah John A. Moran Eye Center
Nov 3, 2022
Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal
Not yet recruiting
- Age-Related Macular Degeneration
- +2 more
- Non-invasive ultrasound retinal stimulation Device
- (no location specified)
Jun 19, 2023
Neovascular Age-related Macular Degeneration Trial in Italy (Brolucizumab)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Ancona, AN, Italy
- +18 more
Aug 10, 2022
Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- BAT5906 injection
- Lucentis
- (no location specified)
Jun 26, 2022
Rhegmatogenous Retinal Detachment, Primary Vitrectomy Trial in Cairo (Pars plana vitrectomy with silicone oil, Pars plana
Recruiting
- Rhegmatogenous Retinal Detachment
- Primary Vitrectomy
- Pars plana vitrectomy with silicone oil
- Pars plana vitrectomy with SF6
-
Cairo, EgyptFaculty of Medicine, Cairo University
May 16, 2022
Diabetic Retinopathy, Macular Edema Trial in Montemorelos (PPV/MP, Intravitreal injection)
Completed
- Diabetic Retinopathy
- Macular Edema
- PPV/MP
- Intravitreal injection
-
Montemorelos, Nuevo Leon, MexicoHospital La Carlota
Nov 20, 2021
Central Visual Impairment, Macular Degeneration Trial in Birmingham (Training visual sensitivity, Combination training)
Recruiting
- Central Visual Impairment
- Macular Degeneration
- Training visual sensitivity
- Combination training
-
Birmingham, AlabamaUAB
Aug 12, 2022
Advanced Glaucoma Progression Study
Active, not recruiting
- Primary Open Angle Glaucoma
- +2 more
-
Los Angeles, CaliforniaUCLA Jules Stein Eye Institute
Oct 15, 2021
Glaucoma Trial in Paris (Electroretinogram Pattern (Diopsys® NOVA System))
Active, not recruiting
- Glaucoma
- Electroretinogram Pattern (Diopsys® NOVA System)
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Neovascular (Wet) Age-related Macular Degeneration (AMD) Trial in United Kingdom (Stereotactic radiotherapy (16 Gray or Sham),
Active, not recruiting
- Neovascular (Wet) Age-related Macular Degeneration (AMD)
- Stereotactic radiotherapy (16 Gray or Sham)
- 0.5 mg ranibizumab
-
Huntingdon, Cambridgeshire, United Kingdom
- +29 more
Apr 1, 2022
The Role of Inflammation in AMD and Related Disorders
Unknown status
- Age-Related Macular Degeneration
- multi-modal cSLO imaging
-
Toronto, Ontario, CanadaSt Michael's Hospital
May 21, 2019
Macular Polypoidal Choroidal Vasculopathy (PCV) Trial in Korea, Republic of (Brolucizumab 6mg)
Not yet recruiting
- Macular Polypoidal Choroidal Vasculopathy (PCV)
- Brolucizumab 6mg
-
Busan, Korea, Republic of
- +13 more
Dec 19, 2022
Macular Corneal Dystrophy Trial in Pristina (Fresh Corneal Lenticule Implantation using Relex-Smile Surgery)
Enrolling by invitation
- Macular Corneal Dystrophy
- Fresh Corneal Lenticule Implantation using Relex-Smile Surgery
-
Pristina, KosovoEye Hospital Pristina
Aug 18, 2021
Focal Laser Single Intravitreal Ranibizumab Retinal Artery
Completed
- Retinal Artery Macroaneurysm
- Dual focal laser and intravitreal Ranibizumab injection
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Thickness of Both Macula and Choroid in Type 2 Diabetes Mellitus
Not yet recruiting
- Diabetic Retinopathy
- Swept Source Optical Coherence Tomography(Topcon DRI Triton)
- (no location specified)
Mar 19, 2023
Diabetic Macular Edema: Relevance of Staging Progression on
Recruiting
- Diabetic Macular Edema
- intravitreal administration of bevacizumab/ranibizumab/aflibercept/desamethazone
-
Lugano, SwitzerlandESASO Scientific Projects
Oct 4, 2021